Toggle light / dark theme

Elicited Repetitive Daily Blindness Associated With Gain-of-Function SCN1A Variants and Responsiveness to Sodium Channel Blockers

Study demonstrates that elicited repetitive daily blindness is a clinical feature in patients with familial hemiplegic migraine 3 because of gain-of-function Nav1.1 variants. Patients in this report responded to sodium channel blocker medications.


This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.

Phosphoinositide Depletion and Compensatory Phospho-Signaling in Angiotensin II-Induced Heart Disease

Westhoff & colleagues found that PTEN inhibition reduces cardiac fibrosis caused by the high blood pressure hormone AngII. Learn how to fight fibrosis from hypertension at.


This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.

Efficacy and Safety of VMAT2 Inhibitors in the Treatment of Huntington DiseaseA Meta-Analysis of Randomized Clinical Trials

In patients with Huntington disease, vesicular monoamine transporter 2 inhibitors (VMAT2is) treatment improved chorea without significant changes in adverse effects or depressive symptoms.


This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.

Influence of Decreased Kidney Function on Plasma Biomarkers of Neurodegenerative Disorders in Routine Care: Confirmation of the Interest of Ratios

This study found that impaired kidney function was linked to increased plasma cerebral amyloidosis biomarkers, but ratio-based measures showed stable sensitivity and specificity for detecting cerebral amyloidosis across all eGFR groups.


This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.

Bitwarden CLI Compromised in Ongoing Checkmarx Supply Chain Campaign

When reached for comment, Bitwarden confirmed the incident and said it stemmed from the compromise of its npm distribution mechanism following the Checkmarx supply chain attack, but emphasized that no end-user data was accessed as part of the attack. The entire statement shared with The Hacker News is reproduced verbatim below

The Bitwarden security team identified and contained a malicious package that was briefly distributed through the npm delivery path for @bitwarden/[email protected] between 5:57 PM and 7:30 PM (ET) on April 22, 2026, in connection with a broader Checkmarx supply chain incident.

The investigation found no evidence that end user vault data was accessed or at risk, or that production data or production systems were compromised. Once the issue was detected, compromised access was revoked, the malicious npm release was deprecated, and remediation steps were initiated immediately.

/* */